Michael Atkins, MD

Michael Atkins, MD

Oncology Boston, MA

Professor of Medical Oncology, Georgetown University


Office Address

  • 330 Brookline Ave
    Kirstein 158
    Boston, MA 02215
    Phone: (616) 667-1930
    Fax: (617) 975-8030

Are you Dr. Atkins?

Claim your profile and join over 60% of U.S. physicians already on Doximity.

Claim this pageNo, this isn't me

Michael Atkins, MD

Oncology Boston, MA

Professor of Medical Oncology, Georgetown University

50 Colleague InvitesIs this you? Register Now to see 50 messages.

Summary

  • Dr. Michael Atkins, MD is a board certified oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and District of Columbia. He is affiliated with Beth Israel Deaconess Medical Center and Milton Hospital.

Clinical Specialties & Interests

  • Oncology: General Oncology

Education & Training

  • Tufts Medical CenterTufts Medical Center
  • Tufts Medical CenterTufts Medical Center
  • Tufts University School of MedicineTufts University School of Medicine

Certifications & Licensure

  • DC State Medical LicenseDC State Medical License2012 - 2016
  • MA State Medical LicenseMA State Medical LicenseActive through 2013
  • American Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineMedical Oncology

    Awards, Honors, & Recognition

    • America's Top DoctorsCastle Connolly, 2014, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006
    • America's Top Doctors for CancerCastle Connolly, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005
    • Top Doctors:Washington DC AreaCastle Connolly, 2012

    Clinical Trials

    Publications & Presentations

    PubMed

    Grant Support

    • Career Development ProgramNational Cancer Institute
      2009 - 2011
    • Df/Hcc Kidney Cancer SporeNational Cancer Institute
      2009 - 2011
    • Developmental Research ProgramNational Cancer Institute
      2009 - 2011
    • Phase 1 Trial Of Twice Weekly IV IL-12 PLUS Low-Dose Subcutaneous IL-2National Center For Research Resources
      2004 - 2004
    • Df/Hcc Renal Cancer SporeNational Cancer Institute
      2003 - 2008
    • Eastern Cooperative Oncology GroupNational Cancer Institute
      2002 - 2012
    • Biologic Therapy Of Melanoma And Renal Cell CancerNational Cancer Institute
      2002 - 2006
    • Core--Clinical Data ManagementNational Cancer Institute
      2002 - 2002
    • Chemo And Cytokine Immunotherapy In High Risk MelanomaNational Cancer Institute
      2001 - 2002
    • Topical Tretinoin /Oral Fenretinide In Dysplastic NevusNational Center For Research Resources
      2000 - 2002
    • Ivrhil 12 W/ Or W/Out Test Dose In Patients W/ Advanced MalignanciesNational Center For Research Resources
      1999 - 2002
    • CNI 1493 &Il 2 In Renal Cell Carcinoma &Melanoma PatientsNational Center For Research Resources
      1999 - 2002
    • IL 2 Administered By IV In Patients With Advanced Malignant MelonomaNational Center For Research Resources
      1998 - 1999
    • RH Interleukin 12 Administered Subcutaneously In Patients With CancerNational Center For Research Resources
      1998 - 1999
    • Trial Of Concurrent Biochemotherapy W/ Cisplatin, Dacarbazine, Vinplastine, IL2National Center For Research Resources
      1998 - 1999
    • IL2 Administered By IV In Patients With Advanced Renal Cell CarcinomaNational Center For Research Resources
      1998 - 2002
    • OPEN Label Non-Random Dose Escalation Study Of RH IL-12 Subcutaneous InjectionNational Center For Research Resources
      1997 - 1997
    • Phase II Pilot Trial Of Concurrent Biochemotherapy With Cisplatin, DacarbazineNational Center For Research Resources
      1997 - 1997
    • Phase I Trial Of High Dose Interleukin 2 With TNF Receptor IGG ChimeraNational Center For Research Resources
      1996 - 1997
    • Chemoprevention Of Prostate Cancer With Finasteride, Phase III IntergroupNational Center For Research Resources
      1996 - 1998
    • Phase III, Randomized, Double Blind, Placebo Controlled Study Of Ct1501rNational Center For Research Resources
      1996 - 1996
    • Phase II Study Of Recombinant IL-6 Administered By ONE Hour InfusionsNational Center For Research Resources
      1996 - 1996
    • Phase I Dose Escalation Study Of Recombinant Human Interleukin 12National Center For Research Resources
      1996 - 1996
    • Phase I Dose Escalating Study Of Recombinant Human Interleukin 12National Center For Research Resources
      1996 - 1996
    • Multipart Phase I Clinical Trial Of High Dose IL 2 In Combination With IL 1National Center For Research Resources
      1996 - 1996

    Alternate Names

    • Dr. Michael Atkins, Dr. Michael Atkins, MD, Dr. M Atkins, Dr. Michael B. Atkins

    Physicians, view Dr. Atkins's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV